<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>DIC Guidelines</title>

  <!-- Bootstrap 5 -->
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet">
  <link rel="stylesheet" href="css/style.css">
</head>
<body class="d-flex flex-column min-vh-100">

<!-- Navbar (same structure as guidelines-hst.html) -->
<nav class="navbar navbar-expand-lg navbar-light bg-light fixed-top shadow-sm">
  <div class="container-fluid px-3 d-flex align-items-center justify-content-between">
    <div class="d-flex align-items-center">
      <a class="navbar-brand d-flex align-items-center" href="#">
        <img src="assets/DYP_LOGO_RED.jpg" alt="DYP Logo" height="50" class="me-2">
      </a>
      <div class="navbar-brand-text d-none d-md-block">
        <strong>Dr. D.Y Patil Pratishthan’s</strong><br>
        Dr. D.Y Patil College of Pharmacy Akurdi, Pune – 411044<br>
        <small class="text-muted">Department of Pharmacy Practice (Pharm. D.)</small>
      </div>
    </div>
    <button class="navbar-toggler ms-2" type="button" data-bs-toggle="collapse" data-bs-target="#navbarContent"
      aria-controls="navbarContent" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>
    <div class="collapse navbar-collapse justify-content-end mt-2 mt-lg-0" id="navbarContent">
      <ul class="navbar-nav">
        <li class="nav-item"><a class="nav-link fw-semibold" href="dic.html">DIC Home</a></li>
        <li class="nav-item"><a class="nav-link fw-semibold" href="dicform.html">Register</a></li>
        <li class="nav-item"><a class="nav-link fw-semibold" href="dic-guidelines.html">Guidelines</a></li>
        <li class="nav-item"><a class="nav-link fw-semibold" href="dic-about-us.html">About Us</a></li>
      </ul>
    </div>
  </div>
</nav>

<!-- Content section -->
<section class="py-5 mt-5">
  <div class="container">
    <h2 class="text-center mb-4">Drug Information Center (DIC) - Guidelines</h2>
    <div class="row justify-content-center">
      <div class="col-lg-10">
        <div class="bg-white p-4 rounded shadow-sm">

<!-- BEGIN: Content copied verbatim from DIC GUIDELINES.docx -->
<p>A Drug Information Center (DIC) is a specialized facility that provides accurate, unbiased, and timely information about drugs and medications to healthcare professionals, patients, and the general public. The primary aim of a DIC is to promote the rational use of medicines by supporting evidence-based decision-making in clinical practice.</p>

<p>DICs serve as a reliable source for drug-related inquiries, including information about drug dosage, interactions, adverse effects, therapeutic uses, and recent advances in pharmacotherapy. They play a critical role in improving patient safety, enhancing the quality of healthcare, and supporting pharmacovigilance activities.</p>

<p><strong>Objectives of the DIC</strong></p>

<ul>
<li>To provide accurate, unbiased, and evidence-based drug information to healthcare professionals, students, and patients.</li>
<li>To promote rational drug use through evaluation of prescriptions and therapeutic interventions.</li>
<li>To monitor and improve drug safety, including adverse drug reactions (ADRs) and medication errors.</li>
<li>To act as a resource for clinical research, education, and professional development.</li>
</ul>

<p><strong>Drug Monograph</strong></p>

<p>A drug monograph is a comprehensive document providing detailed information on a particular drug, including:</p>

<ul>
<li>Chemical name &amp; structure</li>
<li>Pharmacology &amp; mechanism of action</li>
<li>Indications &amp; contraindications</li>
<li>Dosage &amp; administration</li>
<li>Adverse effects &amp; toxicity</li>
<li>Drug interactions</li>
<li>Special precautions</li>
</ul>

<p>Example: Monograph for Metformin:</p>

<ul>
<li>Indication: Type 2 Diabetes Mellitus</li>
<li>Contraindication: Renal impairment (eGFR &lt;30 mL/min/1.73 m²)</li>
<li>Adverse effects: GI upset, lactic acidosis (rare)</li>
</ul>

<p><strong>Rx Express Intro</strong></p>

<p>RxExpress is a newsletter published by the Drug Information Center to provide timely updates on drugs, therapies, regulatory changes, safety alerts, and recent research findings. It serves as a knowledge-sharing platform for students, healthcare professionals, and faculty.</p>

<p><strong>Objectives:</strong></p>

<ol>
<li>Keep healthcare professionals informed about new drug approvals, recalls, and safety alerts.</li>
<li>Promote awareness of latest clinical guidelines and treatment protocols.</li>
<li>Disseminate research highlights, case studies, and innovations in pharmacotherapy.</li>
<li>Support rational prescribing and evidence-based practice.</li>
</ol>

<p><strong>Content Included in RxExpress:</strong></p>

<ul>
<li>New Drug Approvals: FDA/CDSCO-approved medications, biosimilar, generics</li>
<li>Example: Announcement of a new oral anticoagulant for atrial fibrillation.</li>

<li>Safety Alerts &amp; Recalls: Adverse drug reactions, black-box warnings, product recalls</li>
<li>Example: Recall of a batch of metformin due to impurity detection.</li>

<li>Clinical Research Updates: Key findings from recent studies or clinical trials</li>
<li>Example: Evidence supporting reduced dose of statins in elderly patients to minimize myopathy.</li>

<li>Regulatory News: Changes in drug schedules, prescription regulations, or licensing</li>
<li>Example: New government guidelines for antibiotic stewardship in hospitals.</li>

<li>Educational Articles: Case studies, drug interaction highlights, or dosing strategies</li>
<li>Example: Case report on drug-induced liver injury due to herbal supplements.</li>
</ul>

<p>Will include “New Approvals,” “Safety Alerts,” “Research Highlights,” “Regulatory News”</p>

<p><strong>Example Entry in RxExpress.</strong></p>

<p>Title: “FDA Approves Oral Antiviral for COVID-19”</p>

<p>Summary: Newly approved drug X reduces hospitalization risk by 50% in mild to moderate COVID-19 patients. Recommended dose: 300 mg twice daily for 5 days. Check for interactions with anticoagulants.</p>

<p><strong>References &amp; Sources</strong></p>

<p>DIC queries should be answered using reliable and updated sources:</p>

<ul>
<li>Primary literature: PubMed, clinical trials</li>
<li>Secondary literature: Review articles, guidelines</li>
<li>Tertiary sources: Lexicomp, Micromedex, Martindale, British National Formulary (BNF)</li>
<li>Official resources: WHO, FDA, CDSCO</li>
</ul>

<p><strong>Types of Cases Handled</strong></p>

<p>The DIC handles a wide variety of queries, including:</p>

<ul>
<li>Dosage Check</li>
<li>Example: Calculating pediatric dose of amoxicillin for a 20 kg child.</li>

<li>Drug Interactions</li>
<li>Example: Checking interaction between fluconazole and warfarin.</li>

<li>Contraindications</li>
<li>Example: Advising against NSAIDs in a patient with peptic ulcer disease.</li>

<li>Drug Safety Profile</li>
<li>Example: Evaluating long-term safety of statins in elderly patients.</li>

<li>Prescription Audit</li>
<li>Example: Reviewing prescriptions in the hospital for polypharmacy risks.</li>

<li>Medication Errors</li>
<li>Example: Identifying wrong dose prescriptions and suggesting correction.</li>

<li>Bioavailability or Alternative Drug</li>
<li>Example: Suggesting IV paracetamol instead of oral for patients unable to swallow.</li>

<li>Dose Calculation</li>
<li>Example: Calculating creatinine clearance to adjust digoxin dose.</li>
</ul>

<p><strong>Process for Responding to Queries</strong></p>

<p>Query Reception: Queries received via email, phone, or in-person.</p>

<p>Data Collection: Collect patient-specific details (age, weight, comorbidities, lab results).</p>

<p>Literature Search: Review primary, secondary, and tertiary sources for accurate information.</p>

<p>Analysis &amp; Recommendation: Evaluate risk-benefit and provide evidence-based advice.</p>

<p>Documentation: Record the query, references used, and advice given.</p>

<p>Feedback: Follow-up to assess outcome or clarify further doubts.</p>

<p>Example: A doctor requests information on anticoagulant dosing in renal impairment. The DIC reviews guidelines, calculates dose adjustments, and documents the advice.</p>

<p><strong>Collaboration and Networking</strong></p>

<p>The DIC collaborates with:</p>

<ul>
<li>Hospital pharmacists and clinicians for patient care</li>
<li>Other DICs and academic institutions for knowledge exchange</li>
<li>Regulatory authorities (CDSCO, FDA, WHO) for drug safety updates</li>
<li>Professional bodies (IPA, AICTE) for continuing education programs.</li>
</ul>

<p>Example: Collaboration with Ruby Hall Clinic to provide workshops on adverse drug reaction reporting.</p>

<p><strong>References</strong></p>

<ul>
<li>American Society of Health-System Pharmacists. ASHP Guidelines on Pharmacy-Based Drug Information Services. 2018.</li>
<li>WHO. Pharmacovigilance Guidelines for Setting Up a Drug Information Center. 2020.</li>
<li>Lexicomp Online, Wolters Kluwer.</li>
<li>Martindale: The Complete Drug Reference, 41st Edition.</li>
<li>British National Formulary (BNF) 2025.</li>
<li>. FDA Drug Safety Communications: www.fda.gov/drugs/drug-safety-and-availability</li>
<li>CDSCO Updates: www.cdsco.gov.in</li>
</ul>

<!-- END: verbatim content -->

        </div>
      </div>
    </div>
  </div>
</section>

<!-- Footer -->
<footer class="bg-light text-center py-3 shadow-sm mt-auto">
  <small class="text-muted">© 2025 Designed & Developed by Gaurav Gaikwad & Kumkum Bhenwal</small>
</footer>

<!-- Scripts -->
<script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
</body>
</html>
